Premium
An engineered CX3CR1 antagonist endowed with anti‐inflammatory activity
Author(s) -
Dorgham Karim,
Ghadiri Ata,
Hermand Patricia,
Rodero Mathieu,
Poupel Lucie,
Iga Mutsumori,
Hartley Oliver,
Gorochov Guy,
Combadière Christophe,
Deterre Philippe
Publication year - 2009
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0308158
Subject(s) - cx3cl1 , cx3cr1 , chemokine , chemotaxis , biology , microbiology and biotechnology , inflammation , chemokine receptor , in vivo , in vitro , internalization , pharmacology , receptor , immunology , biochemistry
Identification of a chemokine analogue that antagonized CX3CL1‐CX3CR1‐dependent responses both in vitro and in vivo
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom